JUNB and chronic myelogenous leukemia, BCR-ABL1 positive: Another case in point in the area of molecular cancer modeling were the reports by Passegué et al. [8] and Santaguida et al. [9] that JunB inactivation recapitulates aspects of human malignancies, including chronic myelogenous leukemia.